A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia

A case report

Chen Chih Yang, Wei Chung Wang, Tu Hsueh Yeh, Tzu Hsuan Chen, Yen Liang Liu, Ming Kuei Lu, Chin Song Lu, Chon Haw Tsai

Research output: Contribution to journalArticle

Abstract

Background Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by early onset dystonia and a dramatic response to relatively low doses of levodopa. The autosomal dominant DRD is caused by mutations in the gene coding GTP cyclohydrolase 1 (GCH1), the enzyme that catalyzes the first step in the biosynthesis of tetrahydrobiopterin. We herein report a novel gene mutation causally links to DRD. Subject and Methods A 23-year-old woman, presented with a history of gait abnormality and leg dystonia at age 15. Her symptoms were worsened especially in recent 2 years prior to visiting neurological clinic. In view of typical diurnal variation of dystonia, a therapeutic trial with levodopa was given and there was a dramatic response. Hence, a diagnosis of DRD was tentatively made. In addition, her father has leg dystonia since his 14 years old with leg tremor. Her 2 uncles and probably her 2 grandaunts also have limbs tremor. Genetic analysis by using PCR-direct sequencing revealed a novel point mutation (c.263G>T: p. Arg88Leu) in GCH1, including her father and asymptomatic eldest sister. Conclusion We here report a Taiwanese family afflicted with DRD due to a novel missense mutation of the GCH1. The clinical features are considerably variable within the family. The findings extend the genotypic and clinical spectrum of DRD.

Original languageEnglish
Pages (from-to)21-23
Number of pages3
JournalClinical Neurology and Neurosurgery
Volume165
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

GTP Cyclohydrolase
Missense Mutation
Dystonia
Genes
Leg
Levodopa
Tremor
Fathers
Mutation
Gait
Point Mutation
Dopa-Responsive Dystonia
Siblings
Polymerase Chain Reaction
Enzymes

Keywords

  • Autosomal-dominant GCH1 deficiency
  • Diurnal fluctuation
  • Dopa-responsive dystonia
  • DYT5a
  • Missense mutation

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia : A case report. / Yang, Chen Chih; Wang, Wei Chung; Yeh, Tu Hsueh; Chen, Tzu Hsuan; Liu, Yen Liang; Lu, Ming Kuei; Lu, Chin Song; Tsai, Chon Haw.

In: Clinical Neurology and Neurosurgery, Vol. 165, 01.02.2018, p. 21-23.

Research output: Contribution to journalArticle

Yang, Chen Chih ; Wang, Wei Chung ; Yeh, Tu Hsueh ; Chen, Tzu Hsuan ; Liu, Yen Liang ; Lu, Ming Kuei ; Lu, Chin Song ; Tsai, Chon Haw. / A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia : A case report. In: Clinical Neurology and Neurosurgery. 2018 ; Vol. 165. pp. 21-23.
@article{6212deb58a124727b8480af9ad3f0b1e,
title = "A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia: A case report",
abstract = "Background Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by early onset dystonia and a dramatic response to relatively low doses of levodopa. The autosomal dominant DRD is caused by mutations in the gene coding GTP cyclohydrolase 1 (GCH1), the enzyme that catalyzes the first step in the biosynthesis of tetrahydrobiopterin. We herein report a novel gene mutation causally links to DRD. Subject and Methods A 23-year-old woman, presented with a history of gait abnormality and leg dystonia at age 15. Her symptoms were worsened especially in recent 2 years prior to visiting neurological clinic. In view of typical diurnal variation of dystonia, a therapeutic trial with levodopa was given and there was a dramatic response. Hence, a diagnosis of DRD was tentatively made. In addition, her father has leg dystonia since his 14 years old with leg tremor. Her 2 uncles and probably her 2 grandaunts also have limbs tremor. Genetic analysis by using PCR-direct sequencing revealed a novel point mutation (c.263G>T: p. Arg88Leu) in GCH1, including her father and asymptomatic eldest sister. Conclusion We here report a Taiwanese family afflicted with DRD due to a novel missense mutation of the GCH1. The clinical features are considerably variable within the family. The findings extend the genotypic and clinical spectrum of DRD.",
keywords = "Autosomal-dominant GCH1 deficiency, Diurnal fluctuation, Dopa-responsive dystonia, DYT5a, Missense mutation",
author = "Yang, {Chen Chih} and Wang, {Wei Chung} and Yeh, {Tu Hsueh} and Chen, {Tzu Hsuan} and Liu, {Yen Liang} and Lu, {Ming Kuei} and Lu, {Chin Song} and Tsai, {Chon Haw}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.clineuro.2017.12.018",
language = "English",
volume = "165",
pages = "21--23",
journal = "Clinical Neurology and Neurosurgery",
issn = "0303-8467",
publisher = "Elsevier",

}

TY - JOUR

T1 - A novel missense mutation of the GTP cyclohydrolase 1 gene in a Taiwanese family with dopa-responsive dystonia

T2 - A case report

AU - Yang, Chen Chih

AU - Wang, Wei Chung

AU - Yeh, Tu Hsueh

AU - Chen, Tzu Hsuan

AU - Liu, Yen Liang

AU - Lu, Ming Kuei

AU - Lu, Chin Song

AU - Tsai, Chon Haw

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Background Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by early onset dystonia and a dramatic response to relatively low doses of levodopa. The autosomal dominant DRD is caused by mutations in the gene coding GTP cyclohydrolase 1 (GCH1), the enzyme that catalyzes the first step in the biosynthesis of tetrahydrobiopterin. We herein report a novel gene mutation causally links to DRD. Subject and Methods A 23-year-old woman, presented with a history of gait abnormality and leg dystonia at age 15. Her symptoms were worsened especially in recent 2 years prior to visiting neurological clinic. In view of typical diurnal variation of dystonia, a therapeutic trial with levodopa was given and there was a dramatic response. Hence, a diagnosis of DRD was tentatively made. In addition, her father has leg dystonia since his 14 years old with leg tremor. Her 2 uncles and probably her 2 grandaunts also have limbs tremor. Genetic analysis by using PCR-direct sequencing revealed a novel point mutation (c.263G>T: p. Arg88Leu) in GCH1, including her father and asymptomatic eldest sister. Conclusion We here report a Taiwanese family afflicted with DRD due to a novel missense mutation of the GCH1. The clinical features are considerably variable within the family. The findings extend the genotypic and clinical spectrum of DRD.

AB - Background Dopa-responsive dystonia (DRD) is a clinical syndrome characterized by early onset dystonia and a dramatic response to relatively low doses of levodopa. The autosomal dominant DRD is caused by mutations in the gene coding GTP cyclohydrolase 1 (GCH1), the enzyme that catalyzes the first step in the biosynthesis of tetrahydrobiopterin. We herein report a novel gene mutation causally links to DRD. Subject and Methods A 23-year-old woman, presented with a history of gait abnormality and leg dystonia at age 15. Her symptoms were worsened especially in recent 2 years prior to visiting neurological clinic. In view of typical diurnal variation of dystonia, a therapeutic trial with levodopa was given and there was a dramatic response. Hence, a diagnosis of DRD was tentatively made. In addition, her father has leg dystonia since his 14 years old with leg tremor. Her 2 uncles and probably her 2 grandaunts also have limbs tremor. Genetic analysis by using PCR-direct sequencing revealed a novel point mutation (c.263G>T: p. Arg88Leu) in GCH1, including her father and asymptomatic eldest sister. Conclusion We here report a Taiwanese family afflicted with DRD due to a novel missense mutation of the GCH1. The clinical features are considerably variable within the family. The findings extend the genotypic and clinical spectrum of DRD.

KW - Autosomal-dominant GCH1 deficiency

KW - Diurnal fluctuation

KW - Dopa-responsive dystonia

KW - DYT5a

KW - Missense mutation

UR - http://www.scopus.com/inward/record.url?scp=85039737011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039737011&partnerID=8YFLogxK

U2 - 10.1016/j.clineuro.2017.12.018

DO - 10.1016/j.clineuro.2017.12.018

M3 - Article

VL - 165

SP - 21

EP - 23

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

ER -